Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients

Pharmacotherapy

Volumn 17, Issue 3, 1997, Pages 457-463

  Min, David I ^a   Chen, Hsiang Yin ^a   Lee, Myung Koo ^a   Ashton, Kay ^a   Martin, Maureen F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DISPOSITION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION;

ADULT; AGED; AREA UNDER CURVE; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030960197     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lemmer B, Brugruerolle B. Chronopharmacokinetics. Are they clinically relevant? Clin Pharmacokinet 1994;26:419-27.
2. Clench J, Reinberg A, Dziewanowska J, Ghata J, Smolensky M. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur J Clin Pharmacol 1981;20:359-69.
3. Nagayama H. Chronopharmacology of psychotropic drugs: circadian rhythms in drug effects and its implications to rhythms in the brain. Pharmacol Ther 1993;59:31-54.
4. Hrushesky W. Chemotherapy timing: an important variable in toxicity and response. In: Perry MC, Yarbo JW, eds. Toxicity of chemotherapy. New York: Grune & Stratton, 1984:449-77.
5. Scott PH, Tabachnik E, McLeod S, et al. Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmaceutics. J Pediatr 1981;99:476-9.
6. Goto T, Kino T, Hatanaka H, et al. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987;19:4-8.
7. Tanaka H, Kuroda A, Marusawa H, et al. Physicochemical properties of FK 506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987;19: 11-16.
8. Jusko WJ, Piekoszewski W, Klintmalm GB, et al. Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther 1995;57:281-90.
9. McCauley J, Fung J, Jain A, Todo S, Starzl TE. The effects of FK 506 on renal function after liver transplantation. Transplant Proc 1990;22(suppl 1):17-20.
10. Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: a new immunosuppressive agent. Am J Health-Syst Pharm 1995;52:1521-35.
11. Kon V, Sugiura M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487-91.
12. Yatscoff RW, Fryer J, Thliveris JA. Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitro. Clin Biochem 1993;26:409-14.
13. Textor C, Burett J, Romero JC, et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK 506 after liver transplantation. Kidney Int 1995;47:1426-33.
14. Bunchman TE. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cell. J Clin Invest 1994;88:310-14.
15. Levin ER. Endothelins. N Engl J Med 1995;333:356-63.
16. Mekki Q, Lee C, Carrier S, et al. The effect of food on oral bioavailability of tacrolimus (FK 506) in liver transplant patients. Clin Pharmacol Ther 1993;53:229.
17. Abbott Laboratories, Diagnostics Division. Transplant diagnostics for tacrolimus assay. Abbott Park, IL: Author, 1993.
18. Min DI, Chen H, Fabrega A, et al. Circadian variation of tacrolimus disposition in liver allograft recipients. Transplantation 1996;62:1190-2.
19. Honcharik N. The effect of food on cyclosporine absorption. Clin Biochem 1991;24:89-92.
20. Fujimura A, Shiga T, Ohashi K, Ebihara A. Chronopharmacokinetic study of a new immunosuppressive agent, FK 506 in mice. Jpn J Pharmacol 1993;61:137-9.
21. Fujimura A, Ebihara A. Administration time-dependent toxicity of a new immunosuppressive agent, tacrolimus (FK 506). Life Sci 1994;55:485-90.
22. Cipolle RJ, Canafax DM, Rabatin J, Bowers LD, Sutherland DER, Hrushesky WJM. Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression. Pharmacotherapy 1988;8(1):47-51.